Regorafenib Supplier-Buyer Network — Trade Flow Analysis

Name: Regorafenib Supplier-Buyer Trade Network Dataset — 60+ Indian Exporters, 4+ Importers, 37+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Regorafenib supplier network, Regorafenib buyers, pharmaceutical export India, Regorafenib trade data

TransData Nexus

Regorafenib

India Pharmaceutical Trade Intelligence

$1.0M60 Suppliers37 CountriesHS 30049099

ExportsIndia → FRANCE73.8%India → THAILAND9.3%

ImportsUNITED STATES → India$246.8K GERMANY → India$125.9K

#1 Supplier: KARDI TRADING

Who Supplies Regorafenib? Top Manufacturers & Buyers 2026 — KARDI TRADING PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1KARDI TRADING PRIVATE LIMITED

KARDI TRADING PRIVATE LIMITED is the first-largest Regorafenib exporter from India, with a market share of 73.8% and a total export value of $743.0K across 8 shipments. Their average shipment value of $92.9K is above the market average of $6.5K, suggesting premium or bulk contract pricing.

KARDI TRADING PRIVATE LIMITED serves 1 named buyer in our database. SOPHAL SPA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• SOPHAL SPA — $743.0K across 8 shipments (100.0% of this supplier's total exports)

Key Insight: KARDI TRADING PRIVATE LIMITED's per-shipment value of $92.9K is 1321% above the market average of $6.5K, consistent with large-order contracts or value-added formulations.

2SANSKRUTI PHARMA

SANSKRUTI PHARMA is the second-largest Regorafenib exporter from India, with a market share of 11.5% and a total export value of $116.0K across 9 shipments. Their average shipment value of $12.9K is above the market average of $6.5K, suggesting premium or bulk contract pricing.

SANSKRUTI PHARMA serves 4 named buyers in our database. STR INTERNATIONAL TRADING CO., LIMITED is the dominant customer, accounting for 54.4% of this supplier's tracked business. Top customers include:

• STR INTERNATIONAL TRADING CO., LIMITED — $63.2K across 5 shipments (54.4% of this supplier's total exports)

• SMC GLOBAL LIMITED — $28.5K across 2 shipments (24.6% of this supplier's total exports)

• STR INTERNATIONAL TRADING CO., LIMITED — $12.2K across 1 shipments (10.5% of this supplier's total exports)

Key Insight: SANSKRUTI PHARMA's per-shipment value of $12.9K is 97% above the market average of $6.5K, consistent with large-order contracts or value-added formulations.

3R.S. SURGIPHARM PRIVATE LIMITED

R.S. SURGIPHARM PRIVATE LIMITED is the third-largest Regorafenib exporter from India, with a market share of 1.3% and a total export value of $12.8K across 11 shipments. Their average shipment value of $1.2K is below the market average of $6.5K, reflecting a high-volume, competitive pricing strategy.

R.S. SURGIPHARM PRIVATE LIMITED serves 3 named buyers in our database. CLIENT CODE PH001, is the dominant customer, accounting for 50.8% of this supplier's tracked business. Top customers include:

• CLIENT CODE PH001, — $6.5K across 6 shipments (50.8% of this supplier's total exports)

• CLIENT CODE PH001, — $4.4K across 4 shipments (34.2% of this supplier's total exports)

• TO THE ORDER — $1.9K across 2 shipments (15.0% of this supplier's total exports)

Key Insight: R.S. SURGIPHARM PRIVATE LIMITED operates with high shipment frequency (11 shipments) at a per-shipment value of $1.2K, indicating a broad distribution network with many smaller, regular orders.

43S CORPORATION

3S CORPORATION is the fourth-largest Regorafenib exporter from India, with a market share of 1.2% and a total export value of $12.0K across 7 shipments. Their average shipment value of $1.7K is below the market average of $6.5K, reflecting a high-volume, competitive pricing strategy.

3S CORPORATION serves 1 named buyer in our database. TO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TO — $12.0K across 7 shipments (100.0% of this supplier's total exports)

Key Insight: 3S CORPORATION operates with high shipment frequency (7 shipments) at a per-shipment value of $1.7K, indicating a broad distribution network with many smaller, regular orders.

5RMPL PHARMA LLP

RMPL PHARMA LLP is the fifth-largest Regorafenib exporter from India, with a market share of 0.9% and a total export value of $9.5K across 3 shipments. Their average shipment value of $3.2K is below the market average of $6.5K, reflecting a high-volume, competitive pricing strategy.

RMPL PHARMA LLP serves 3 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 79.9% of this supplier's tracked business. Top customers include:

• TO THE ORDER — $7.6K across 2 shipments (79.9% of this supplier's total exports)

• TO THE ORDER — $1.7K across 1 shipments (18.1% of this supplier's total exports)

• TO THE ORDER — $195 across 0 shipments (2.1% of this supplier's total exports)

Key Insight: RMPL PHARMA LLP operates with high shipment frequency (3 shipments) at a per-shipment value of $3.2K, indicating a broad distribution network with many smaller, regular orders.

6LEOWIN HEALTHCARE LLP

LEOWIN HEALTHCARE LLP is the fifth-largest Regorafenib exporter from India, with a market share of 0.9% and a total export value of $9.4K across 12 shipments. Their average shipment value of $780 is below the market average of $6.5K, reflecting a high-volume, competitive pricing strategy.

LEOWIN HEALTHCARE LLP serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FOR THE ORDER OF — $3.8K across 5 shipments (40.3% of this supplier's total exports)

• NA — $2.8K across 4 shipments (29.9% of this supplier's total exports)

• FOR THE ORDER OF RAK — $2.8K across 4 shipments (29.7% of this supplier's total exports)

Key Insight: LEOWIN HEALTHCARE LLP operates with high shipment frequency (12 shipments) at a per-shipment value of $780, indicating a broad distribution network with many smaller, regular orders.

1France

France ranks as the first-largest destination for Regorafenib imports from India, with a total trade value of $743.0K across 0 shipments — representing a 73.8% share of all Regorafenib exports. The average shipment value of $743.0K is above the global average of $6.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: France's per-shipment average of $743.0K (11265% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Regorafenib imports from India.

Primary Market

Secondary Market

2Thailand

Thailand ranks as the second-largest destination for Regorafenib imports from India, with a total trade value of $93.3K across 9 shipments — representing a 9.3% share of all Regorafenib exports. The average shipment value of $10.4K is above the global average of $6.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Regorafenib importers in Thailand: STR INTERNATIONAL TRADING CO., LTD is the largest buyer, accounting for 67.7% ($63.2K) of this market's total imports.

• STR INTERNATIONAL TRADING CO., LTD — $63.2K (67.7% of Thailand's total)

• STR INTERNATIONAL TRADING CO. LIMITED — $12.2K (13.0% of Thailand's total)

• STR INTERNATIONAL TRADING CO., LIMITED — $12.2K (13.0% of Thailand's total)

Key Insight: Thailand's per-shipment average of $10.4K (58% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Thailand is a key market for Regorafenib imports from India.

Primary Market

Secondary Market

3Kenya

Kenya ranks as the third-largest destination for Regorafenib imports from India, with a total trade value of $36.1K across 0 shipments — representing a 3.6% share of all Regorafenib exports. The average shipment value of $36.1K is above the global average of $6.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Kenya's per-shipment average of $36.1K (452% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Kenya is a key market for Regorafenib imports from India.

Primary Market

Secondary Market

4Hong Kong

Hong Kong ranks as the fourth-largest destination for Regorafenib imports from India, with a total trade value of $28.5K across 0 shipments — representing a 2.8% share of all Regorafenib exports. The average shipment value of $28.5K is above the global average of $6.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Hong Kong's per-shipment average of $28.5K (336% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Hong Kong is a key market for Regorafenib imports from India.

Primary Market

Secondary Market

5Iraq

Iraq ranks as the fifth-largest destination for Regorafenib imports from India, with a total trade value of $18.6K across 10 shipments — representing a 1.8% share of all Regorafenib exports. The average shipment value of $1.9K is below the global average of $6.5K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Regorafenib importers in Iraq: SKIN LINE LOGISTIC is the largest buyer, accounting for 24.9% ($4.6K) of this market's total imports.

• SKIN LINE LOGISTIC — $4.6K (24.9% of Iraq's total)

• ZMC EXPRESS CARGO FZCO — $4.3K (23.2% of Iraq's total)

Key Insight: Iraq receives frequent, smaller shipments of Regorafenib — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Iraq is a key market for Regorafenib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Regorafenib.
2.Flow Mapping: 60 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 154 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 37 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

154 Verified Shipments

60 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Regorafenib

Regorafenib

Who Supplies Regorafenib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Regorafenib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Regorafenib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1KARDI TRADING PRIVATE LIMITED

2SANSKRUTI PHARMA

3R.S. SURGIPHARM PRIVATE LIMITED

43S CORPORATION

5RMPL PHARMA LLP

6LEOWIN HEALTHCARE LLP

From Indian Factories to Global Pharmacies — How Regorafenib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Regorafenib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1France

2Thailand

3Kenya

4Hong Kong

5Iraq

People Also Ask — Regorafenib Supplier & Trade Network

Regorafenib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology